Reply To: Anti-Carbamylated Protein Antibodies (Anti-CarP) and Higher Baseline Disease Activity in RA, a Replication Study in Three Cohorts
Arthritis and Rheumatology- United Kingdom
doi 10.1002/art.40677
Full Text
Abstract
Available in
Date
October 27, 2018
Authors
Publisher
Wiley